Watanabe T - Search Results

1

[Genetic testing for effective Herceptin therapy].

Watanabe T, Katsumata N, Ando M, Mukai H, Shimizu C, Kitagawa R, Saijo NG. Watanabe T, et al. Nihon Rinsho. 2002 Mar;60(3):603-11. Nihon Rinsho. 2002. PMID: 11904980 Review. Japanese.

2

[Treatment guidelines for systemic adjuvant therapy of breast cancer].

Watanabe T, Mukai H. Watanabe T, et al. Nihon Rinsho. 2006 Mar;64(3):419-23. Nihon Rinsho. 2006. PMID: 16529030 Japanese.

3

[Recent advance in adjuvant therapy for breast cancer].

Shimizu C, Watanabe T. Shimizu C, et al. Among authors: watanabe t. Gan To Kagaku Ryoho. 2002 Dec;29(13):2458-69. Gan To Kagaku Ryoho. 2002. PMID: 12506467 Review. Japanese.

4

Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel.

Mukai H, Watanabe T, Ando M, Katsumata N. Mukai H, et al. Among authors: watanabe t. Int J Clin Oncol. 2003 Feb;8(1):23-5. doi: 10.1007/s101470300002. Int J Clin Oncol. 2003. PMID: 12601538

5

Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan.

Kouno T, Katsumata N, Mukai H, Ando M, Watanabe T. Kouno T, et al. Among authors: watanabe t. Jpn J Clin Oncol. 2003 Jun;33(6):309-13. doi: 10.1093/jjco/hyg062. Jpn J Clin Oncol. 2003. PMID: 12913086

6

Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.

Shimizu C, Hasegawa T, Tani Y, Takahashi F, Takeuchi M, Watanabe T, Ando M, Katsumata N, Fujiwara Y. Shimizu C, et al. Among authors: watanabe t. Hum Pathol. 2004 Dec;35(12):1537-42. doi: 10.1016/j.humpath.2004.09.005. Hum Pathol. 2004. PMID: 15619214

7

An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients.

Mukai H, Watanabe T, Ando M, Katsumata N. Mukai H, et al. Among authors: watanabe t. Jpn J Clin Oncol. 2006 Dec;36(12):808-10. doi: 10.1093/jjco/hyl108. Epub 2006 Nov 14. Jpn J Clin Oncol. 2006. PMID: 17105737

8

Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed.

Mukai H, Watanabe T, Ando M, Shimizu C, Katsumata N. Mukai H, et al. Among authors: watanabe t. Breast Cancer Res Treat. 2009 Jan;113(1):123-8. doi: 10.1007/s10549-007-9889-9. Epub 2008 Jan 10. Breast Cancer Res Treat. 2009. PMID: 18193480

9

Safety and efficacy of a combination of docetaxel and cisplatin in patients with unknown primary cancer.

Mukai H, Katsumata N, Ando M, Watanabe T. Mukai H, et al. Among authors: watanabe t. Am J Clin Oncol. 2010 Feb;33(1):32-5. doi: 10.1097/COC.0b013e31819ccc55. Am J Clin Oncol. 2010. PMID: 19786850 Clinical Trial.

10

The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.

Mizuno T, Katsumata N, Mukai H, Shimizu C, Ando M, Watanabe T. Mizuno T, et al. Among authors: watanabe t. Support Care Cancer. 2007 Mar;15(3):287-91. doi: 10.1007/s00520-006-0126-6. Epub 2006 Aug 29. Support Care Cancer. 2007. PMID: 16941132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,199 results

Search Page

Filters